SAN DIEGO, Calif., Feb. 21, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, subsidiary, HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the Company’s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat patients in the country suffering from Multiple Sclerosis.
Tag Archives: Multiple Sclerosis
Ireland is to become the latest country to legalise the use of cannabis for treating specific medical conditions.
On Nov. 8, 2016, Denmark announced that it will launch a medical cannabis trial program in 2018, as reported by AFP.
A Fox 2 Detroit news anchor has announced she will retire from the television station to work with a pro-marijuana group in Michigan. Anqunette Jamison Sarfoh, a 22-year veteran of broadcast journalism, is slated to be introduced as a new leader in MILegalize at a fundraiser in Ann Arbor, Mich., on Nov. 2, 2016.
On Oct. 2, 2016, Germany’s Federal Institute for Drugs and Medical Devices, the country’s medical regulatory authority, confirmed that a patient suffering from multiple sclerosis in Mannheim, Germany, will be granted permission to cultivate up to 130 medical cannabis plants for personal use per year in his home.
National pharmacies in Croatia are now dispensing medical marijuana. According to Malay Mail Online, medical marijuana products hit the shelves in July and prospective patients are beginning to show interest in it.
On July 29, 2016, television star and medical marijuana activist Montel Williams was detained in Germany while on vacation with his family. According to TMZ, Williams was briefly detained at Frankfurt Airport after authorities in customs discovered a small bag of marijuana kief in his luggage.
FORT WORTH, Texas, Feb. 22, 2016 /Weed Wire/ — The Southwest Cannabis Conference & Expo is pleased to announce special celebrity keynote speaker Montel Williams for the largest Texas cannabis conference in history.
Alan Brochstein has followed quite closely recent developments in the medical and financial world insofar as they have affected GW Pharmaceuticals (NASDAQ: GWPH), the developer of two promising cannabis-based medications.
Montel Williams, the former host of his eponymous show, has become a full-time veterans’ rights crusader recently and now he’s wading into Florida politics with a pitch for the medical-marijuana constitutional amendment.
LONDON, Oct 8 (Reuters) – A pioneering cannabis drug developed by British firm GW Pharmaceuticals for treating spasticity in multiple sclerosis has been rejected as not cost-effective in the company’s home market.